Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Konstantin Kazankov, Simon Mark Dahl Baunwall, Karen Louise Thomsen, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 3, pp. 145-159
Closed Access | Times Cited: 746

Showing 1-25 of 746 citing articles:

Chronic inflammation in the etiology of disease across the life span
David Furman, Judith Campisi, Eric Verdin, et al.
Nature Medicine (2019) Vol. 25, Iss. 12, pp. 1822-1832
Open Access | Times Cited: 3423
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1254
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1913-1928
Open Access | Times Cited: 490
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 421
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada, Águeda González‐Rodríguez, Carmelo García‐Monzón, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 373
Macrophage Polarization and Its Role in Liver Disease
Cheng Wang, Cheng Ma, Lihong Gong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 364
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 355
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 303
Liver Macrophages: Old Dogmas and New Insights
Adrien Guillot, Frank Tacke
Hepatology Communications (2019) Vol. 3, Iss. 6, pp. 730-743
Open Access | Times Cited: 287
Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Adel Hammoutène, Pierre‐Emmanuel Rautou
Journal of Hepatology (2019) Vol. 70, Iss. 6, pp. 1278-1291
Open Access | Times Cited: 275
Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes
Teh‐Wei Wang, Yoshikazu Johmura, Narumi Suzuki, et al.
Nature (2022) Vol. 611, Iss. 7935, pp. 358-364
Closed Access | Times Cited: 261
Metabolism of tissue macrophages in homeostasis and pathology
Stefanie K. Wculek, Gillian Dunphy, Ignacio Heras‐Murillo, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 3, pp. 384-408
Open Access | Times Cited: 259
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH
Sabine Daemen, Anastasiia Gainullina, Gowri Kalugotla, et al.
Cell Reports (2021) Vol. 34, Iss. 2, pp. 108626-108626
Open Access | Times Cited: 247
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque, Gyöngyi Szabó, Manal F. Abdelmalek, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 24-39
Closed Access | Times Cited: 244
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 240
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Yun Ji, Yuan Gao, Hong Chen, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2062-2062
Open Access | Times Cited: 198
Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis
Wei Chen, Aiting Yang, Jidong Jia, et al.
Hepatology (2020) Vol. 72, Iss. 2, pp. 729-741
Closed Access | Times Cited: 195
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 487-503
Closed Access | Times Cited: 191
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
D. van der Heide, Ralf Weiskirchen, Ruchi Bansal
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 190
Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
Tingting Yan, Nana Yan, Ping Wang, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 1, pp. 3-18
Open Access | Times Cited: 177
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 165
TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis
Jinchao Hou, Jue Zhang, Ping Cui, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 162
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
Chiara Rosso, Konstantin Kazankov, Ramy Younes, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 5, pp. 1012-1021
Closed Access | Times Cited: 160
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 552-566
Closed Access | Times Cited: 158
Macrophage functional diversity in NAFLD — more than inflammation
Emelie Barreby, Ping Chen, Myriam Aouadi
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 8, pp. 461-472
Closed Access | Times Cited: 157
Page 1 - Next Page

Scroll to top